Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes

被引:639
作者
Rahmoune, H [1 ]
Thompson, PW [1 ]
Ward, JM [1 ]
Smith, CD [1 ]
Hong, GZ [1 ]
Brown, J [1 ]
机构
[1] GlaxoSmithKline Inc, Addenbrookes Hosp, Clin Pharmacol Unit, Human Biomarkers Ctr, Cambridge CB2 2GG, England
关键词
D O I
10.2337/diabetes.54.12.3427
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The bulk of glucose that is filtered by the renal glomerulus is reabsorbed by the glucose transporters of the proximal convoluted tubular epithelium. However, it has been difficult to investigate this in diseases such as type 2 diabetes because of the inability to isolate primary renal cells from patients without a renal biopsy. We report here a method for the immunomagnetic isolation and novel primary culture of human exfoliated proximal tubular epithelial cells (HEPTECs) from fresh urine. The primary isolates are highly enriched and differentiated and express characteristic proximal tubular phenotypic markers. They continue to express the proximal tubular markers CD13/aminopeptidase-N, sodium glucose cotransporter (SGLT) 2, and alkaline phosphatase through up to six subsequent subcultures in a similar way to human proximal cells isolated from renal biopsies. In a hyperglycemic environment, HEPTECs isolated from patients with type 2 diabetes expressed significantly more SGLT2 and the facilitative glucose transporter GLUT2 than cells from healthy individuals. We also demonstrated a markedly increased renal glucose uptake in HEPTECs isolated from patients with type 2 diabetes compared with healthy control subjects. Our findings indicate for the first time in a human cellular model that increased renal glucose transporter expression and activity is associated with type 2 diabetes.
引用
收藏
页码:3427 / 3434
页数:8
相关论文
共 47 条
[1]   T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats [J].
Adachi, T ;
Yasuda, K ;
Okamoto, Y ;
Shihara, N ;
Oku, A ;
Ueta, K ;
Kitamura, K ;
Saito, A ;
Iwakura, T ;
Yamada, Y ;
Yano, H ;
Seino, Y ;
Tsuda, K .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (08) :990-995
[2]  
[Anonymous], PACIFIC EC REV
[3]   Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na+-glucose cotransporter inhibitor T-1095 [J].
Arakawa, K ;
Ishihara, T ;
Oku, A ;
Nawano, M ;
Ueta, K ;
Kitamura, K ;
Matsumoto, M ;
Saito, A .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (02) :578-586
[4]  
Baer PC, 1999, EXP NEPHROL, V7, P306
[5]   Isolation of proximal and distal tubule cells from human kidney by immunomagnetic separation [J].
Baer, PC ;
Nockher, WA ;
Haase, W ;
Scherberich, JE .
KIDNEY INTERNATIONAL, 1997, 52 (05) :1321-1331
[6]   The generalized aminoaciduria seen in patients with hepatocyte nuclear factor-1α mutations is a feature of all patients with diabetes and is associated with glucosuria [J].
Bingham, C ;
Ellard, S ;
Nicholls, AJ ;
Pennock, CA ;
Allen, J ;
James, AJ ;
Satchell, SC ;
Salzmann, MB ;
Hattersley, AT .
DIABETES, 2001, 50 (09) :2047-2052
[7]  
Bluher M, 2002, DIABETES, V51, pA326
[8]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[9]   Changes in facilitative glucose transporter messenger ribonucleic acid levels in the diabetic rat kidney [J].
Chin, E ;
Zamah, AM ;
Landau, D ;
Gronboek, H ;
Flyvbjerg, A ;
Leroith, D ;
Bondy, CA .
ENDOCRINOLOGY, 1997, 138 (03) :1267-1275
[10]  
CHRISTIAN M, 1998, J CLIN INVEST, V102, P619